Lv12
30 积分 2022-06-15 加入
Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease
51分钟前
待确认
Chapter 13 - Leptomeningeal metastasis
4小时前
已关闭
Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era
1天前
已完结
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases
1天前
已完结
PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations
30天前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
1个月前
已完结
BAY 2927088: The first non-covalent, potent, and selective tyrosine kinase inhibitor targeting EGFR exon 20 insertions and C797S resistance mutations in NSCLC
1个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
2个月前
已完结
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结
CEND-1: a game changer for pancreatic cancer chemotherapy?
2个月前
已完结
皖公网安备34019202002308
